Product Information
TIAGABINE HCL 4 MG TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $2.0631 per EA under NDC 00093503156. Its NADAC has been published 517 times since Aug 3, 2016.
Strength
4 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093503156
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
TIAGABINE HYDROCHLORIDEApproval Type
Authorized Generic (NDA)
FDA Application
NDA020646On Market Since
6/3/2016
Pharmacological Classes
Price Statistics
The NADAC for TIAGABINE HCL 4 MG TABLET has been published 517 times since Aug 3, 2016, and over the history we have for it it has declined 60.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.0631 per EA |
|---|---|
| All-time high | $6.0403 (Aug 16, 2017) |
| All-time low | $1.6211 (Nov 19, 2025) |
| 52-week high | $2.2835 |
| 52-week low | $1.6211 |
| Median price | $3.7347 |
| Average price | $3.7561 |
| Largest weekly change | +43.0% (Mar 20, 2024) |
| Weeks tracked | 517 |
| Tracking since | Aug 3, 2016 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of TIAGABINE HCL 4 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TIAGABINE HCL 4 MG TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $2.0631 per EA (NDC 00093503156), effective Jun 24, 2026.
How has the price of TIAGABINE HCL 4 MG TABLET changed over time?
Over the history we have for it, the NADAC for TIAGABINE HCL 4 MG TABLET has declined 60.3%. It has been tracked across 517 weekly CMS publications since Aug 3, 2016.
What are the highest and lowest recorded NADAC prices for TIAGABINE HCL 4 MG TABLET?
Since Aug 3, 2016, the NADAC for TIAGABINE HCL 4 MG TABLET has ranged from a low of $1.6211 (Nov 19, 2025) to a high of $6.0403 (Aug 16, 2017), with a median of $3.7347 per EA.
Are there cheaper alternatives to TIAGABINE HCL 4 MG TABLET?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as TIAGABINE HCL 4 MG TABLET, but none are currently priced below it.
Who manufactures TIAGABINE HCL 4 MG TABLET?
TIAGABINE HCL 4 MG TABLET (NDC 00093503156) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification